Copyright Reports & Markets. All rights reserved.

Global Gastric Volvulus Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Gastric Volvulus Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Medication
    • 1.3.3 Surgery
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Gastric Volvulus Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Homecare
    • 1.4.4 Specialty Clinics
    • 1.4.5 Others
  • 1.5 Global Gastric Volvulus Treatment Market Size & Forecast
    • 1.5.1 Global Gastric Volvulus Treatment Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Gastric Volvulus Treatment Sales Quantity (2021-2032)
    • 1.5.3 Global Gastric Volvulus Treatment Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Fresenius SE
    • 2.1.1 Fresenius SE Details
    • 2.1.2 Fresenius SE Major Business
    • 2.1.3 Fresenius SE Gastric Volvulus Treatment Product and Services
    • 2.1.4 Fresenius SE Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Fresenius SE Recent Developments/Updates
  • 2.2 Mallinckrodt
    • 2.2.1 Mallinckrodt Details
    • 2.2.2 Mallinckrodt Major Business
    • 2.2.3 Mallinckrodt Gastric Volvulus Treatment Product and Services
    • 2.2.4 Mallinckrodt Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mallinckrodt Recent Developments/Updates
  • 2.3 Mayne Pharma Group Limited
    • 2.3.1 Mayne Pharma Group Limited Details
    • 2.3.2 Mayne Pharma Group Limited Major Business
    • 2.3.3 Mayne Pharma Group Limited Gastric Volvulus Treatment Product and Services
    • 2.3.4 Mayne Pharma Group Limited Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mayne Pharma Group Limited Recent Developments/Updates
  • 2.4 Mylan N.V.
    • 2.4.1 Mylan N.V. Details
    • 2.4.2 Mylan N.V. Major Business
    • 2.4.3 Mylan N.V. Gastric Volvulus Treatment Product and Services
    • 2.4.4 Mylan N.V. Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Mylan N.V. Recent Developments/Updates
  • 2.5 Par Pharmaceutical
    • 2.5.1 Par Pharmaceutical Details
    • 2.5.2 Par Pharmaceutical Major Business
    • 2.5.3 Par Pharmaceutical Gastric Volvulus Treatment Product and Services
    • 2.5.4 Par Pharmaceutical Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Par Pharmaceutical Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Gastric Volvulus Treatment Product and Services
    • 2.6.4 Pfizer Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 Sawai Pharmaceutical
    • 2.7.1 Sawai Pharmaceutical Details
    • 2.7.2 Sawai Pharmaceutical Major Business
    • 2.7.3 Sawai Pharmaceutical Gastric Volvulus Treatment Product and Services
    • 2.7.4 Sawai Pharmaceutical Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sawai Pharmaceutical Recent Developments/Updates
  • 2.8 Sun Pharmaceutical Industries
    • 2.8.1 Sun Pharmaceutical Industries Details
    • 2.8.2 Sun Pharmaceutical Industries Major Business
    • 2.8.3 Sun Pharmaceutical Industries Gastric Volvulus Treatment Product and Services
    • 2.8.4 Sun Pharmaceutical Industries Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sun Pharmaceutical Industries Recent Developments/Updates
  • 2.9 Teva Pharmaceutical Industries
    • 2.9.1 Teva Pharmaceutical Industries Details
    • 2.9.2 Teva Pharmaceutical Industries Major Business
    • 2.9.3 Teva Pharmaceutical Industries Gastric Volvulus Treatment Product and Services
    • 2.9.4 Teva Pharmaceutical Industries Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 2.10 Tris Pharma
    • 2.10.1 Tris Pharma Details
    • 2.10.2 Tris Pharma Major Business
    • 2.10.3 Tris Pharma Gastric Volvulus Treatment Product and Services
    • 2.10.4 Tris Pharma Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Tris Pharma Recent Developments/Updates
  • 2.11 Vintage Labs
    • 2.11.1 Vintage Labs Details
    • 2.11.2 Vintage Labs Major Business
    • 2.11.3 Vintage Labs Gastric Volvulus Treatment Product and Services
    • 2.11.4 Vintage Labs Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Vintage Labs Recent Developments/Updates
  • 2.12 Zydus Group
    • 2.12.1 Zydus Group Details
    • 2.12.2 Zydus Group Major Business
    • 2.12.3 Zydus Group Gastric Volvulus Treatment Product and Services
    • 2.12.4 Zydus Group Gastric Volvulus Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zydus Group Recent Developments/Updates

3 Competitive Environment: Gastric Volvulus Treatment by Manufacturer

  • 3.1 Global Gastric Volvulus Treatment Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Gastric Volvulus Treatment Revenue by Manufacturer (2021-2026)
  • 3.3 Global Gastric Volvulus Treatment Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Gastric Volvulus Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Gastric Volvulus Treatment Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Gastric Volvulus Treatment Manufacturer Market Share in 2025
  • 3.5 Gastric Volvulus Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Gastric Volvulus Treatment Market: Region Footprint
    • 3.5.2 Gastric Volvulus Treatment Market: Company Product Type Footprint
    • 3.5.3 Gastric Volvulus Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Gastric Volvulus Treatment Market Size by Region
    • 4.1.1 Global Gastric Volvulus Treatment Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Gastric Volvulus Treatment Consumption Value by Region (2021-2032)
    • 4.1.3 Global Gastric Volvulus Treatment Average Price by Region (2021-2032)
  • 4.2 North America Gastric Volvulus Treatment Consumption Value (2021-2032)
  • 4.3 Europe Gastric Volvulus Treatment Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Gastric Volvulus Treatment Consumption Value (2021-2032)
  • 4.5 South America Gastric Volvulus Treatment Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Gastric Volvulus Treatment Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 5.2 Global Gastric Volvulus Treatment Consumption Value by Type (2021-2032)
  • 5.3 Global Gastric Volvulus Treatment Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 6.2 Global Gastric Volvulus Treatment Consumption Value by Application (2021-2032)
  • 6.3 Global Gastric Volvulus Treatment Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 7.2 North America Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 7.3 North America Gastric Volvulus Treatment Market Size by Country
    • 7.3.1 North America Gastric Volvulus Treatment Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Gastric Volvulus Treatment Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 8.2 Europe Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 8.3 Europe Gastric Volvulus Treatment Market Size by Country
    • 8.3.1 Europe Gastric Volvulus Treatment Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Gastric Volvulus Treatment Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Gastric Volvulus Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Gastric Volvulus Treatment Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Gastric Volvulus Treatment Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 10.2 South America Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 10.3 South America Gastric Volvulus Treatment Market Size by Country
    • 10.3.1 South America Gastric Volvulus Treatment Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Gastric Volvulus Treatment Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Gastric Volvulus Treatment Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Gastric Volvulus Treatment Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Gastric Volvulus Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Gastric Volvulus Treatment Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Gastric Volvulus Treatment Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Gastric Volvulus Treatment Market Drivers
  • 12.2 Gastric Volvulus Treatment Market Restraints
  • 12.3 Gastric Volvulus Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Gastric Volvulus Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Gastric Volvulus Treatment
  • 13.3 Gastric Volvulus Treatment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Gastric Volvulus Treatment Typical Distributors
  • 14.3 Gastric Volvulus Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Gastric Volvulus Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Gastric volvulus is a medical emergency and requires prompt treatment to relieve the twisting of the stomach, restore blood flow, and prevent complications.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Gastric Volvulus Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Gastric Volvulus Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Gastric Volvulus Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Gastric Volvulus Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Gastric Volvulus Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Gastric Volvulus Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Gastric Volvulus Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius SE, Mallinckrodt, Mayne Pharma Group Limited, Mylan N.V., Par Pharmaceutical, Pfizer, Sawai Pharmaceutical, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Tris Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Gastric Volvulus Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medication
    Surgery
    Market segment by Application
    Hospitals
    Homecare
    Specialty Clinics
    Others
    Major players covered
    Fresenius SE
    Mallinckrodt
    Mayne Pharma Group Limited
    Mylan N.V.
    Par Pharmaceutical
    Pfizer
    Sawai Pharmaceutical
    Sun Pharmaceutical Industries
    Teva Pharmaceutical Industries
    Tris Pharma
    Vintage Labs
    Zydus Group
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Gastric Volvulus Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Gastric Volvulus Treatment, with price, sales quantity, revenue, and global market share of Gastric Volvulus Treatment from 2021 to 2026.
    Chapter 3, the Gastric Volvulus Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Gastric Volvulus Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Gastric Volvulus Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Gastric Volvulus Treatment.
    Chapter 14 and 15, to describe Gastric Volvulus Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now